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Abstract
Brugada syndrome (BrS) is an inherited disease associated with ST elevation
in the right precordial leads, polymorphic ventricular tachycardia (PVT), and
sudden cardiac death in adults. Mutations in the cardiac sodium channel
account for a large fraction of BrS cases. BrS manifests in the right ventricle
(RV), which led us to examine the biophysical and molecular properties of
sodium channel in myocytes isolated from the left (LV) and right ventricle.
Patch clamp was used to record sodium current (INa) in single canine RV and
LV epicardial (epi) and endocardial (endo) myocytes. Action potentials were
recorded from multicellular preparations and single cells. mRNA and proteins
were determined using quantitative RT-PCR and Western blot. Although LV
wedge preparations were thicker than RV wedges, transmural ECG recordings
showed no difference in the width of the QRS complex or transmural conduc-
tion time. Action potential characteristics showed RV epi and endo had a
lower Vmax compared with LV epi and endo cells. Peak INa density was signifi-
cantly lower in epi and endo RV cells compared with epi and endo LV cells.
Recovery from inactivation of INa in RV cells was slightly faster and half maxi-
mal steady-state inactivation was more positive. b2 and b4 mRNA was
detected at very low levels in both ventricles, which was confirmed at the pro-
tein level. Our observations demonstrate that Vmax and Na
+ current are smal-
ler in RV, presumably due to differential Nav1.5/b subunit expression. These
results provide a potential mechanism for the right ventricular manifestation
of BrS.
Introduction
Brugada syndrome (BrS) is an inherited disease associated
with ST elevation or a broad J-wave in the right precor-
dial leads, phase 2 reentry, polymorphic ventricular tachy-
cardia (PVT), and sudden cardiac death in adults
(Brugada and Brugada 1992). The ECG pattern of BrS is
often concealed, but can be unmasked or modulated by
several factors including a number of Na+ channel inhibi-
tors (Rolf et al. 2003).
The mechanisms underlying the syndrome are still
being debated. Originally, BrS was linked to sudden car-
diac death in adults with minor or no structural abnor-
malities in the heart (Brugada and Brugada 1992).
However, recent studies suggest a pathophysiological
component in hearts from BrS patients such as increased
fibrosis and fatty infiltration as well as decreased connexin
proteins, particularly in the right ventricular outflow tract
(RVOT) leading to right ventricular conduction slowing.
This is the basis of the depolarization hypothesis, and it
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appears that BrS is associated with fibrosis, whether or
not patients carry a SCN5A mutation (Nademanee et al.
2015). The repolarization hypothesis relies on an imbal-
ance in depolarizing and repolarizing currents in the early
parts of the cardiac action potential (AP). A decrease in
inward sodium channel currents or an increased transient
outward K+ currents (Ito) during phase 1 will accentuate
the spike-and-dome morphology of the action potential
mainly in the right ventricle (RV) epicardium (epi) gener-
ating a transmural voltage gradient that leads to the char-
acteristic ECG changes (Calloe et al. 2009; Cordeiro et al.
2009) (for review see Wilde et al. (2010)). Both hypothe-
sis have clinical and experimental support and may not
be mutually exclusive.
Several genes have been linked to the development of
BrS (for review see Sarquella-Brugada et al. (2016). The
most prevalent gene linked to BrS is mutations in the
SCN5A encoding the Nav1.5 channel a-subunit account-
ing for at least 30% of the BrS cases (Nielsen et al. 2013).
Other mutations linked to BrS include SCN1B encoding
the sodium channel b1-subunit (Watanabe et al. 2008),
and the glycerol-3-phosphate dehydrogenase 1 gene (Lon-
don et al. 2007), all of which lead to a reduction in peak
sodium channel current (INa). Besides mutations affecting
the sodium current, mutations in calcium channel sub-
units resulting in a loss of function have been reported
(Antzelevitch et al. 2007; Cordeiro et al. 2009) as well as
mutations resulting a gain of function of Ito (Delpon
et al. 2008; Giudicessi et al. 2011; Ohno et al. 2011).
Interestingly, despite the fact that mutations in SCN5A
would affect all Na+ channels in the heart, often these
mutations only manifest in a chamber-specific manner.
For example, several SCN5A mutations have been linked
to atrial fibrillation with no ventricular manifestations
noted in the patients (Darbar et al. 2008). Similar obser-
vations have been noted in the ventricles (i.e., BrS and
Long QT syndrome [LQTS]) (3) with no atrial manifesta-
tions. Presumably, a loss-of-function mutation in Nav1.5
would affect all Na+ channels in the ventricle; yet, BrS
typically manifests in only the RV. In addition, a fle-
cainide challenge which would also inhibit INa in both
chambers often unmasks BrS only in the right ventricle.
Previous studies have shown that there are tissue-specific
differences in INa in the canine heart. It is well established
that Purkinje fibers have a high Vmax and the largest INa
in the heart, as they are adapted for rapid conduction
(Gilmour and Zipes 1980). We and others have found
that atrial INa has a higher current density and a more
negative steady-state mid-inactivation potential compared
to ventricular INa (Li et al. 2002; Burashnikov et al. 2007;
Calloe et al. 2011), resulting in a larger proportion of
Na+ channels in atria residing in the inactivated state at
normal resting membrane potentials (Calloe et al. 2011).
In the left ventricle, epi INa has a significantly more nega-
tive steady-state mid-inactivation potential compared with
endodardial (endo) (Cordeiro et al. 2008). Similar to
atrial INa, the more negative steady-state mid-inactivation
potential will tend to leave a larger fraction of endo INa
channels in an inactivated state (Li et al. 2002; Burash-
nikov et al. 2007).
We hypothesize that differential expression of INa and
regional differences in INa kinetics may explain why BrS is
predominantly affecting RV. In this study, we isolated
canine ventricular myocytes from RV and LV regions of
the heart and examined the biophysical and molecular
differences in peak Na+ current. Results of our study
showed that RV cells exhibited a lower peak Na+ current
compared to LV cells; no dramatic difference on steady-
state activation or inactivation was observed. Molecular
analysis revealed that RV tissue cells had a differential
expression of the various subunits that comprise voltage-
gated Na+ channels consistent with the lower INa density.
Our findings indicate that Na+ current is smaller in RV
cells and may contribute to the right ventricular manifes-
tation of BrS.
Methods
Adult mongrel dogs of either sex (age 1–4 years) were
used for all experiments and this investigation conforms
to the Guide for Care and Use of Laboratory Animals
published by the National Institutes of Health (The
Eighth Edition of the Guide for the Care and Use of Labo-
ratory Animals [NRC 2011]). All protocols were approved
by the Institutional Animal Care and Use Committee.
Dogs were anticoagulated with heparin (1000 U/kg. i.v.)
and anesthetized with pentobarbital (30–35 mg/kg, i.v.).
The chest was open via a left thoracotomy, the heart
excised, and placed in cold cardioplegic solution of the
following composition (in mmol/L): NaCl 129, KCl 12,
NaH2PO4 0.9, NaHCO3 20, CaCl2 1.8, MgSO4 0.5, and
glucose 5.5.
Ventricular wedge preparation
Transmural RV or LV wedges of up to 3 9 2 cm were
dissected and cannulated through a branch of the right
coronary artery or the left anterior descending coronary
artery, respectively. The preparations were initially arteri-
ally perfused with cold cardioplegic solution. Subse-
quently, the wedges were placed in a tissue bath and
perfused with Tyrode’s solution of the following composi-
tion (mmol/L): 129 NaCl, 4 KCl, 0.9 NaH2PO4, 20
NaHCO3, 1.8 CaCl2, 0.5 MgSO4, 5.5 glucose, and buffered
with 95% O2 and 5% CO2 (37.0  0.5°C). The perfusate
was delivered at a constant pressure (45–50 mmHg).
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Transmural ECGs were recorded using two Ag/AgCl half
cells placed at  1 cm from the epi surface (+) and endo
surface () of the preparation. APs were simultaneously
recorded from the epi and endo surface using floating
microelectrodes filled with 2.7 mol/L KCl (10–30 MΩ).
Pacing was delivered to the endo surface at twice diastolic
threshold at a basic cycle length (BCL) = 1 sec. Record-
ings were obtained using a high-input-impedance amplifi-
cation system (Electro 705 Electrometer, World Precision
Instruments). The signals were digitized at 20 kHz (model
1401 AD/DA system, Cambridge Electronic Designs
[C.E.D.]) using Spike 2 acquisition software (C.E.D.). All
amplified signals were analyzed using Spike 2 for Win-
dows (Cambridge Electronic Design [CED], Cambridge,
UK).
Isolated tissue action potential recordings
Right ventricle or left ventricle epi slices (~2 mm thick)
were isolated using a dermatome (Davol, Cranston, RI)
and superfused with Tyrode’s solution. All preparations
were allowed to equilibrate until the action potentials
reached steady state. Tissues were stimulated at basic cycle
lengths (BCL) of 500–2000 msec (2–5 msec pulse dura-
tion) delivered through Teflon-coated silver bipolar elec-
trodes. Transmembrane action potentials were recorded
from tissue using glass microelectrodes filled with
2.7 mol/L KCl. Electronic equipment similar to the one
described in the Ventricular Wedge Preparation section
was used.
Isolation of ventricular cells
Left ventricle or right ventricle cells were prepared as pre-
viously described with minor modifications (Di Diego
et al. 2002; Calloe et al. 2010). Left ventricular or right
ventricular wedge preparations were dissected out and
initially perfused with nominally Ca2+-free solution
(mmol/L): NaCl 129, KCl 5.4, MgSO4 2.0, NaH2PO4 0.9,
glucose 5.5, NaHCO3 20, and bubbled with 95% O2/5%
CO2 containing 0.1% BSA for a period of about 5 min.
The preparation was then subjected to enzyme digestion
with the nominally Ca2+-free solution supplemented with
0.5 mg/mL collagenase (Type II, Worthington), 0.1 mg/
mL protease (Type XIV, Sigma), and 1 mg/mL BSA for
8–12 min. For isolation of ventricular cells, thin slices of
tissue (approximately 2 mm thick) from the epi and endo
were shaved from the wedge using a dermatome (Davol,
Cranston, RI). The tissue slices were then placed in sepa-
rate beakers, minced, and incubated in fresh buffer con-
taining 0.5 mg/mL collagenase, 1 mg/mL BSA, and
agitated. The supernatant was filtered, centrifuged at
200 rpm for 2 min, and the myocyte-containing pellet
was stored in 0.5 mmol/L Ca2+ HEPES buffer at room
temperature.
AP recordings from single myocytes
APs from ventricular cells were recorded using whole cell
patch pipettes coupled to a MultiClamp 700A amplifier
(Axon Instruments, Foster City, CA) as previously
described (Murphy et al. 2011; Cordeiro et al. 2012; Cal-
loe et al. 2016). Briefly, cells were superfused with HEPES
buffer of the following composition (mmol/L): 126 NaCl,
5.4 KCl, 1.0 MgCl2, 1.8 CaCl2, 10 HEPES, and 11 glucose.
pH adjusted to 7.4 with NaOH. The patch pipette
solution had the following composition (in mmol/L):
90 K-aspartate, 45 KCl, 1.0 MgCl2, 5 EGTA, 5 MgATP, 5
HEPES, and 10 NaCl (pH 7.2 with KOH). The resistance
of the electrodes was 2–4 MΩ when filled with the pipette
solution. APs were elicited using a 3-msec current pulse
at 120% threshold amplitude, and cells were paced at
cycle lengths of 0.5 and 1 Hz. APs were acquired at
50 kHz and filtered at 5 kHz.
Voltage clamp recordings of peak INa
Early sodium current, INa, was measured as previously
described with minor modifications (Cordeiro et al. 2008;
Calloe et al. 2011). Experiments were performed using a
MultiClamp 700A (Molecular Devices, Foster City, CA).
Command voltages were delivered and data acquired via
a DigiData 1322 computer interface using pClamp 9
(Molecular Devices) with data stored on computer hard
disk. Patch pipettes were pulled from borosilicate glass
(1.5 mm o.d. and 1.1 mm i.d.) on a Model PP-830 verti-
cal puller (Narashige Instruments, Japan). The electrode
resistance was 0.9–2.0 MΩ when filled with the internal
solution (see below). The membrane was ruptured by
applying negative pressure and series resistance compen-
sated by 75–80%. Whole cell current data were acquired
at 20–50 kHz and filtered at 5 kHz. Currents were nor-
malized to cell capacitance.
External solution contained (in mmol/L): NaCl 15,
Choline Cl 120, Na+ acetate 2.8, CaCl2 0.5, KCl 4, MgCl2
1.5, CoCl2 1, glucose 10, HEPES 10, NaOH 5, BaCl2 0.1,
and pH adjusted to 7.4 with NaOH/HCl. The pipette
solution contained (mmol/L): CsF 120, NaCl 15, MgCl2
1, KCl 5, HEPES 10, Na2ATP 4, EGTA 10, and pH = 7.2
with CsOH. Peak sodium current was dramatically
reduced in the low extracellular sodium to ensure ade-
quate voltage control, as gauged by the slope of a Boltz-
mann fit to the steady-state activation curve (Kaab et al.
1996). When measuring sodium channel kinetics and
density the holding potential was 120 mV to recruit all
available sodium channels. In addition, recordings of INa
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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were made 5 min after rupture to minimize the effects of
time-dependent negative shift of steady-state inactivation
that occurs in conventional voltage clamp experiments.
Whole cell currents were analyzed using Clampfit 9
(Molecular Devices).
Quantitative real-time PCR
qPCR analysis was performed with the QuantStudio 6
Flex Real-Time PCR System (Applied Biosystems, CA).
Total RNA was extracted with RNAeasy Micro (cells),
Trizol, and/or Mini Kits (tissues) (Qiagen, CA). One
thousand nanogram total RNA from each of the pooled
PVC cells/tissues or atrial tissue samples was reverse tran-
scribed with SuperScriptTM First Strand Synthesis System
for RT-PCR (Invitrogen, CA). Real-time PCR was per-
formed in triplicates for every sample using primers listed
in Table 1. Using SYBR Green/ROX probe (Thermo
Fisher, MA), averaged Ct values of each qPCR reaction
from the target gene were normalized with the average Ct
values of the housekeeping gene 18S, which ran in the
same reaction plate to obtain the ΔCt value (Barajas-Mar-
tinez et al. 2017; Goodrow et al. 2017). Expression was
normalized from ΔCt values for each gene against refer-
ence housekeeping gene 18S, using the formula 2ΔΔCt
(1 9 106) (Livak and Schmittgen 2001):
Western blotting
Protein analysis was performed as previously described
with minor modifications (Barajas-Martinez et al. 2009;
Calloe et al. 2010). Ventricular tissue from three dogs was
snap frozen in liquid nitrogen and stored in 80°C prior
to protein isolation. Membrane proteins were isolated
using the Proteo Extract Native Membrane Kit (Cal-
biochem) according to the manufacturer’s protocol. Pro-
tein concentration was determined by BCA assay (Pierce
BCA Protein Assay). Samples were denatured 10 min at
65°C with 355 mmol/L b-mercaptoethanol, separated on
precast polyacrylamide 4–15% Tris-HCl gels (BioRad)
and transferred to polyvinylidene fluoride (PVDF) mem-
branes. The PVDF membranes were incubated overnight
at 4°C with the following primary antibodies. Rabbit
polyclonal Anti-Nav b1-b4 (1:3000 dilution, Alomone
Labs) and mouse monoclonal antitubulin (1:3000,
Abcam) were used as a loading control. Secondary anti-
bodies were HRP-conjugated goat anti-rabbit IgG
(1:10000, BioRad) and goat anti-mouse IgG (1:10000,
Bio-Rad).
Statistics
Results are presented as Mean  SEM. Statistical analysis
was performed using an ANOVA test followed by a Stu-
dent–Newman–Keuls test or a Student’s t-test, as appro-
priate, using SigmaStat software. A P < 0.05 was
considered statistically significant.
Results
As an initial basis of comparison, APs and the transmural
ECG were simultaneously recorded from both the right
and left ventricular wedge preparation. Figure 1 shows AP
recordings from epi and endo layers (upper and middle
traces) and the corresponding ECG (lower trace) from a
right and left wedge preparation paced at BCL of
1000 msec. The epi recording from the RV wedge showed
a much larger phase 1 repolarization compared to the LV
wedge epi recording, as previously described (Calloe et al.
2010). The endo recording was similar in RV and LV
preparations. Although the thickness of the LV wedge was
always greater than the RV wedge, analysis of the trans-
mural conduction time revealed no significant difference
between RV and LV wedges (13.7  2.0 msec vs.
15.0  1.6 msec, respectively; n = 8). Table 2 summarizes
the electrophysiological parameters from the wedge exper-
iments.
The similarity in conduction velocity across the ventric-
ular wall even though the thickness of the wedges was dif-
ferent suggests that (1) RV wedges have a lower upstroke
velocity (an indirect assessment of Na+ channel current)
and/or (2) RV wedges have a greater gap junctional resis-
tance. As floating microelectrodes do not provide an
accurate measure of upstroke velocity, we measured
Table 1. Oligonucleotide sequences of the primers used for RT-PCR.
Gene name Forward primer Reverse primer
SCN5A CACCATGTGCATCGTCCTTAAC CCATGAGGCTCAGGATGACAAT
SCN1B TCTTCTTCGAGAACTACGAG CATACATCATGATCTCCGAC
SCN2B TACACAGTGAACCACAAAC CAGGTTAATGATCTTCATGC
SCN3B ATATTGCTACAGGAAGGTCTC GCTCTCTTTGTTCTCTGA
SCN4B AAATTCAGCTCATAGACGG CTTTCTTTAGTGGAACCCTC
18S CGCCGCTAGAGGTTGAAATTC TCCGACTTTCGTTCTTGATTAATG
2018 | Vol. 6 | Iss. 14 | e13787
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upstroke velocity in RV and LV epi and endo tissue slices.
Thin sheets of epi or endo muscle were shaved from the
right or left ventricle using a dermatome and APs were
measured using high-resistance microelectrodes (Fig. 2).
Both RV and LV Epi slices exhibited a spike and dome
morphology with RV tissue showing a greater phase 1
repolarization. Analysis of Vmax showed that LV epi had a
higher Vmax (217.2  15.2 V/sec, n = 4) compared to RV
epi (183.3  14.3 V/sec, n = 4, P < 0.05). Similarly, LV
endo had a slightly higher Vmax (216.2  17.3 V/sec,
n = 4) compared to RV endo (198.1  18.8 V/sec, n = 4,
P = N.S.) suggesting that LV tissue may have a greater
INa density compared to RV tissue. Table 3 summarizes
the electrophysiological parameters from the tissue slice
experiments.
We further examined Vmax in single epi and endo cells
isolated from the RV and LV (described in Methods).
Similar to results obtained in tissue slices, analysis of Vmax
at the cellular level revealed that the LV had a higher
Vmax (353.4  12.7 V/sec, n = 9 for LV epi and
336.1  15.6 V/s, n = 8 for LV endo) than cells isolated
from the RV (303.4  15.4 V/sec, n = 9 for RV epi and
288.1  21.0 V/sec, n = 9 for RV endo).
The differences in Vmax observed between LV and RV
may suggest that Na+ current in LV tissue may be larger.
To test this hypothesis, we measured peak INa in epi and
endo cells isolated from the RV and LV. Peak INa was
measured in low extracellular sodium buffer and at room
temperature to ensure adequate voltage control. Represen-
tative INa traces recorded from a LV epi and endo cell are
shown (Fig. 3A and B). Analysis of the I–V relation
(Fig. 3C) showed that peak INa density was larger in LV
epi cells compared to RV epi cells (70.0  9.2 pA/pF
vs. 55.1  5.6 pA/pF, respectively, P < 0.05) but no
Figure 1. Representative recordings of endocardial (endo) and epicardial (epi) action potentials (APs) and the corresponding transmural-ECG
(ECG) obtained from a RV and LV preparation. Preparations were stimulated from the endo surface at a BCL = 1 sec. Although LV preparations
were thicker than RV preparations, the superimposed ECGs show that transmural conduction time was similar.
Table 2. Electrophysiological parameters from wedges.
LV Epi RV Epi LV Endo RV Endo
APD50 135.2  4.7 msec (n = 8) 147.8  5.8 msec (n = 8) 165.8  3.9 msec (n = 8) 162.3  4.5 msec (n = 8)
APD90 165.8  3.9 msec (n = 8) 181.5  5.3 msec (n = 8)1 200.8  2.5 msec (n = 8) 205.68  3.0 msec (n = 8)
Notch, Ph1% of Ph0 15.4  4.9% (n = 8) 22.5  3.2% (n = 8)1 13.9  1.7% (n = 8) 14.4  2.6% (n = 8)
Notch, Ph1% of Ph0 13.2  2.7% (n = 8) 21.0  2.9% (n = 8)1 2.1  2.1% (n = 8) 5.2  2.1% (n = 8)
1Significantly different versus LV Epi (P < 0.05).
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shift in the activation threshold was noted. Similarly, INa
density was larger in LV endo cells compared to RV endo
cells (68.9  6.6 pA/pF vs. 50.8  4.4 pA/pF, respec-
tively, P < 0.05) (Fig. 3). We also measured steady-state
activation from the I–V curves. Chord conductance was
determined using the ratio of current to the electromotive
potential for the cells shown Panels C and D and a Boltz-
mann curve was fit to the data. Analysis of steady-state
activation showed mid-activation voltages (V1/2) of
43.53  0.42 mV, k = 5.03  0.33 for LV epi and
38.51  0.25 mV, k = 4.87  0.21 for RV epi (Fig. 3E).
Similarly, mid-activation voltages (V1/2) of
45.43  0.35 mV, k = 5.51  0.32 for LV endo and
43.25  0.45 mV, k = 4.83  0.40 for RV endo
(Fig. 3F).
We next evaluated steady-state inactivation in LV and
RV cells. After application of 500 msec prepulses, a test
pulse to 20 mV was applied and peak current was nor-
malized to the maximum current and plotted as a func-
tion of the prepulse voltage. A Boltzmann function was
then fit to the data. Representative traces recorded from
LV epi (Fig. 4A) and LV endo cells (Fig. 4B) are shown.
Figure 4C shows there was a small but significant differ-
ence in the mid-inactivation potential between LV and
RV epi cells (V1/2 = 83.6  0.07 mV, k = 5.36  0.06
for LV epi vs. V1/2 = 75.3  0.08 mV, k = 5.76  0.07
for RV epi, P < 0.05). Similarly, Figure 4D shows there
was a small but significant difference in the mid-inactiva-
tion potential between LV and RV endo cells (V1/
2 = 75.7  0.13 mV, k = 7.07  0.11 for LV endo vs.
V1/2 = 70.3  0.08 mV, k = 5.77  0.07 for RV endo,
P < 0.05).
In the next series of experiments, we determined if
recovery from inactivation of INa was different in the four
cell types. Recovery was determined using a standard
double-pulse protocol separated by various time intervals
(voltage clamp protocol shown at top of figure). Repre-
sentative traces recorded from a LV epi and endo cell
showing INa recovery at holding potential of 100 mV
(Fig. 5A–B). Recovery of INa was slightly slower in LV
cells compared to RV cells (Fig. 5C–D). In LV epi, reacti-
vation of INa had a fast and slow phase of recovery as fol-
lows: (1) s1 = 14.5  0.85 msec and s2 = 65.7 
9.7 msec. In contrast, RV epi cells exhibited a faster
recovery from inactivation as follows: (1) s1 = 9.5 
0.49 msec and s2 = 51.9  6.2 msec (P < 0.05 for fast
and slow phase). In LV endo, reactivation of INa had a
fast and slow phase of recovery: (1) s1 = 12.8 
0.57 msec and s2 = 45.6  2.5 msec. Similarly, RV endo
cells exhibited a faster recovery from inactivation as fol-
lows: (1) s1 = 8.9  0.81 msec and s2 = 36.9  4.7 msec
(P < 0.05 for fast and slow phase).
Our biophysical results show a lower density of INa in
RV epi and endo cells compared to LV epi and endo cells.
In addition, other biophysical differences in the
Left Endo
Left Epi
Right Endo
Right Epi
200 ms
200 ms200 ms
200 ms
50 mV
100 V/s
50 mV
100 V/s
50 mV
100 V/s
50 mV
100 V/s
Figure 2. Representative action potentials and corresponding Vmax
recordings from RV and LV epi and endo slices. AP recordings were
taken from preparations paced at a BCL = 1 sec using recordings
high-resistance microelectrodes.
Table 3. Electrophysiological parameters from tissue slices.
LV Epi RV Epi LV Endo RV Endo
APD50 145.8  16.3 msec (n = 4) 138.7  4.6 msec (n = 4) 150.7  16.1 msec (n = 4) 125.7  13.6 msec (n = 4)
APD90 194.9  12.2 msec (n = 4) 163.8  6.5 ms (n = 4) 222.4  9.4 ms (n = 4) 195.1  3.0 msec (n = 4)
AP amplitude 100.7  4.5 mV (n = 4) 91.4  1.7 mV (n = 4) 107.8  4.0 mV (n = 4) 99.1  2.5 mV (n = 4)
Resting
membrane
potential
91.7  1.6 mV (n = 4) 87.3  1.2 mV (n = 4) 91.5  1.8 mV (n = 4) 90.2  1.3 mV (n = 4)
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biophysical properties between RV and LV cells such as
V1/2 of steady-state inactivation and different time courses
of recovery from inactivation were noted. These observa-
tions may suggest differences in the levels of the main
alpha subunit Nav1.5 or the primary beta subunits
(Navb1-b4). We next examined mRNA expression levels
of SCN5A (encoding Nav1.5) and SCN1B-4B (encoding
b1-4 subunit isoforms) in tissue isolated from the LV and
RV. The expression for each Na+ channel subunit was
compared to the housekeeping gene (18S) using quantita-
tive RT-PCR analysis (Fig. 6). We found that the alpha
subunit, SCN5A, was the highest gene expressed com-
pared with the beta subunits in the canine heart. These
results show no difference in expression of SCN5A in the
LV versus the RV. Results obtained for the beta subunits
showed no significant difference in mRNA between RV
and LV. However, epi cells expressed more Navb1 com-
pared to endo cells. Western blot analysis showed Navb1
and Navb3 were expressed at high levels in both ventricle
but no significant differences were noted in the ventricu-
lar chambers (Fig. 7). mRNA levels of Navb2 and b4 were
expressed at very low levels compared to Navb1 and b3
and analysis of Navb2 and Navb4 revealed that the pro-
tein appears to be absent in both LV and RV tissue (data
not shown), in agreement with RT-PCR experiments.
Discussion
Our results show important biophysical and molecular
differences in peak INa. The LV wall is thicker than the
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RV wall, but transmural conduction time was similar
between the two chambers, suggesting less INa in the RV.
Voltage clamp analysis confirmed this observation as
there was a lower density of peak INa in both RV epi and
endo cells compared to LV epi and endo cells. Measure-
ments of other biophysical properties showed that LV epi
and endo cells had a more negative steady-state inactiva-
tion V½ and slower recovery from inactivation compared
to RV epi and endo cells. Examination of the sodium
channel subunits showed no significant LV versus RV dif-
ferences in the levels of SCN5A or SCN1B-SCN4B expres-
sion. Interestingly, SCN2B and SCN4B expression was
virtually absent in both LV and RV tissue. The slower
conduction time in RV is likely attributable to the lower
INa density in RV versus LV. Our results may partially
explain why mutations in SCN5A (resulting in lower peak
INa) tend to predominantly affect the RV resulting in the
Brugada phenotype.
Previous studies have observed regional variations in
the biophysical properties of INa. For example, studies
have demonstrated a larger INa density in atria compared
to ventricle (Li et al. 2002; Burashnikov et al. 2007;
Calloe et al. 2011). Within the dog ventricle, we found
that ventricular LV epi and LV endo have equivalent INa
densities, but epi INa had a more negative steady-state
mid-inactivation potential compared to endo (Cordeiro
et al. 2008). In contrast, an epi-endo gradient of INa was
measured in mice (Veerman et al. 2017).
Biophysical and molecular analysis of INa
Differences in the biophysical properties of RV versus
LV sodium channel manifestation, such as INa kinetics
and magnitude, suggest differences in the makeup of
the corresponding channel complex. It is known that
INa in cardiac myocytes primarily reflects the activity of
the Nav1.5 isoform (Maier et al. 2002; Haufe et al.
2005), but it is not wholly defined by the pore-forming
Nav1.5 a-subunit. Other ‘auxiliary’ proteins, including
several b-subunits, are also involved. Interestingly, epi
cells for either chamber expressed higher levels of
Navb1 message compared to endo cells from the same
chamber (Fig. 6), however, at protein level the differ-
ence between epi and endo was not significant, and
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there was a general tendency toward more protein in
LV compared to RV. The expression of Navb3 subunits
was similar in LV versus RV cells and we could not
detect Navb2 or Navb4 at either the message or protein
level suggesting these particular subunits are not present
in dog ventricle. Studies have shown that the presence
of Navb subunits can facilitate trafficking of Nav1.5 a
channel subunit to the membrane, shift the INa steady-
state inactivation curve, and alter the rate of INa recov-
ery from inactivation (Isom 2001). A recent study
showed that the molecular mechanism responsible for
differences in INa in atria versus ventricular rat cells
could be attributed to lower Navb2 and Navb4 expres-
sion in atria compared to that in ventricle (Chen et al.
2016). The authors speculate the lower expression of
these beta subunits is responsible for the distinct bio-
physical properties of INa in atria, namely, a more neg-
ative steady-state inactivation, and a faster activation
and inactivation. The authors further demonstrate a dif-
ferential sensitivity of INa to the Na
+ channel blocker
dronedarone (Chen et al. 2016). However, as Navb2
and Navb4 expression is essentially absent from canine
ventricular cells, these subunits are unlikely to con-
tribute to the RV versus LV differences in canine INa
we demonstrate in this study.
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Besides b-subunits, other ‘auxiliary’ proteins and inter-
acting proteins such as Ankyrin-B impart differential bio-
physical properties to cardiac INa depending on their
specific constituency (Isom et al. 1994; Mohler et al.
2004; Boukens et al. 2013). Interestingly there are numer-
ous studies highlighting the interplay between INa and Ito.
For example, HEY2 was found to modulate the amplitude
of both Ito and INa in mice and was shown to be involved
in the epi-endo gradient of both currents (Veerman et al.
2017). In another study, the Ito b-subunit KChIP2 was
involved in regulating INa density (Nassal et al. 2016) in
guinea pigs (a species that lacks Kv4.3 and Ito). These
studies further confirm that the biophysical properties of
INa are not solely due to Nav1.5 and Navb1- Navb4.
Differences under pathophysiological
conditions
To our knowledge this is the first study examining INa
density between LV and RV cells. Our results show there
are significant differences in the inactivation characteris-
tics, recovery, and density of Na+ channels in the two
chambers. Consistent with our observations, a recent
study demonstrated that acute sodium current inhibition
in mouse hearts (with tetrodotoxin) resulted in fre-
quency-dependent conduction velocity slowing in the RV
only, with the LV unaffected. The authors suggested that
normal structural heterogeneities present in the RV are
responsible for increased vulnerability to conduction
slowing in the presence of reduced sodium channel func-
tion (Kelly et al. 2018). Alternatively, other studies have
shown lower Na+ channel expression in the RVOT com-
pared to the RV and have implicated the RVOT as the
main origin of arrhythmias in BrS (Boukens et al. 2013).
No matter the mechanism, this reduction in INa in the
right ventricle may become important when other factors,
such as SCN5A mutations, result in a loss of function.
These SCN5A mutations would likely reduce INa in both
chambers; however, it is clear that RV has less of a “depo-
larization” reserve than LV. Interestingly, Ito is larger in
right ventricular epi compared to the left (Di Diego et al.
1996), resulting in a more prominent phase 1 repolariza-
tion compared to LV. This would lead to a greater
depression of RV tissue, as the balance between inward
and outward currents already favors the repolarizing
forces and leads to conditions favorable for the develop-
ment of the BrS phenotype due to loss of the dome (Cal-
loe et al. 2009). The lower INa density together with the
higher Ito density in the RV may explain why BrS mainly
manifests in the RV (Brugada and Brugada 1992; Di
Diego et al. 2002; Calloe et al. 2009).
Clinical implications
BrS has been linked to decreased inward currents or
increased outward currents during phase 1, accentuating
the spike-and-dome morphology of the AP mainly in the
epicardium (Calloe et al. 2009; Cordeiro et al. 2009).
Two opposing hypothesis have been put forward to
describe these observations (for review, see Wilde et al.
(2010)). Our results would indicate that both the repolar-
ization and the depolarization hypothesis can play a role
in the development of BrS. Furthermore, it is clear that
there is a differential expression of INa and Ito as well as
other currents in different regions of the heart (Clark
et al. 1993; Li et al. 2002; Calloe et al. 2011). It is likely
that there are deviations in the levels of expression of the
different currents (e.g., Ito vs. INa) in different individuals,
which may explain why the same mutation can manifest
in different phenotypes, even within the same family.
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